Following the divestiture of Food Ingredients, management frames CapEx at 5-6% of sales, with closer to 6% in the near term to fund high-return initiatives within the Remainco transformation. R&D remains a key driver, rising to about 9% of sales, and the company emphasizes strong cash generation and a disciplined reinvestment cycle designed to lift growth and margins as sales expand.
Generated by Dafinchi AI. Source-grounded AI analysis, not investment advice.
What did management say about Capex and reinvestment post-divestiture?
How they framed the Capex level: Management tied the Capex target to a broader “transformation/investment thesis” for Remainco (Scent, Taste, and Health & Biosciences), emphasizing continued reinvestment to “set ourselves apart” and a reinforcing cycle: invest → improve growth → expand margin → reinvest again. 1
Bottom line (from management’s own framing): After divesting Food Ingredients, IFF management expected to run CapEx around 5%–6% of sales, with the higher end (~6%) for the next 1–2 years to fund high-return initiatives, while simultaneously emphasizing continued reinvestment in innovation (notably R&D ~8%–9% of sales and ~9% currently) to support growth and margin expansion. 123
Disclaimer: The output generated by dafinchi.ai, a Large Language Model (LLM), may contain inaccuracies or "hallucinations." Users should independently verify the accuracy of any mathematical calculations, numerical data, and associated units, as well as the credibility of any sources cited. The developers and providers of dafinchi.ai cannot be held liable for any inaccuracies or decisions made based on the LLM's output.
Post-divestiture, IFF signals a Capex target of 5-6% of sales, with near-term leaning toward ~6% to fund high-return initiatives. Reinvestment is anchored in R&D/innovation for the Remainco, with R&D running around 8-9% of sales and potential increases as sales grow.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF outlines post-divestiture Capex targets of roughly 5-6% of sales, with near-term guidance near the upper end to fund high-return initiatives, while prioritizing R&D reinvestment to support the Remainco growth and margin expansion. The discussion also covers stranded costs, cash-flow framing, and near-term working-capital headwinds tied to the divestiture.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, IFF signals a disciplined capital allocation plan focused on a 5%-6% Capex target, with a near-term tilt toward 6%. It also emphasizes sustained R&D investment (about 8%-9% of sales, now around 9%) to drive growth and margin expansion.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, IFF outlines a disciplined capex framework of about 5-6% of sales, with a near-term tilt toward the upper end to fund high-return initiatives. Reinvestment remains anchored in R&D at 8-9% of sales within the Remainco strategy, alongside a stranded-cost remediation plan to protect margins and lift cash flow as the company progresses toward 2027 and 2028.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, management outlines a Capex path of about 5-6% of sales, with near-term spending at ~6% to fund high-return initiatives, while reinvestment—especially in R&D—remains central to the Remainco strategy and margin expansion. They expect the remaining portfolio to generate sufficient cash flow to support this plan, despite divestiture-related working-capital headwinds.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF explains Capex targeting 5-6% of sales post-divestiture, with near-term activity closer to 6% due to high-return initiatives. The company reaffirms a Remainco strategy focused on ongoing reinvestment, especially in R&D and innovation, to sustain growth and margin expansion.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF outlines a post-divestiture capex plan of about 5%–6% of sales, with near-term movement toward the upper end due to high-return initiatives. Management ties reinvestment to an innovation loop—driving higher R&D spend (approximately 9% of sales) and stronger Remainco cash flow—while noting working-capital headwinds related to the divestiture and expecting 2026 free cash flow to exceed 2025.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, IFF signals a disciplined capex path of 5–6% of sales with a near-term tilt to ~6% for high-return projects, funded by a Remainco strategy that relies on 8–9% of sales for R&D. Stranded costs of about $100 million are to be phased out over 12–24 months, underpinning anticipated better cash flow.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF outlines a disciplined reinvestment plan after the divestiture, targeting capex of 5-6% of sales (around 6% near term) to fund high-return initiatives. R&D is maintained at 8-9% of sales to sustain growth and margin expansion.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF outlines a post-divestiture capital plan: CapEx remains targeted at 5–6% of sales, with management aiming near 6% in the next 1–2 years to fund high-return initiatives and ongoing innovation. The focus shifts to the Remainco businesses while roughly $100 million of stranded costs linger, with two-thirds expected to be eliminated within 12 months and the remainder in the following year.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, IFF signals a disciplined reinvestment path: Capex targeted at 5-6% of sales with a bias toward 6% in the near term, and R&D around 8-9% of sales. The plan pairs ongoing reinvestment with debt reduction and a significant buyback, and positions Remainco as a cash-generative engine with 2026 free cash flow to improve despite near-term margin pressures.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF Management projects Capex at 5%-6% of sales after the Food Ingredients divestiture, with near-term spend skewing toward the upper end due to high-return initiatives. Reinvestment is anchored in Remainco growth through R&D at 8%-9% of sales and targeted cash-flow improvements, including a mid-to-high-teens free cash flow conversion.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Dafinchi